Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng Gee Lim

Showing results (71-80 of 241) with videos related to

Pageof 25
Sort By:
Journal of Gastroenterology and Hepatology|June 15, 2007
How should we manage patients with non-alcoholic fatty liver disease in 2007?Henry L-Y Chan, H Janaka de Silva, Nancy W-Y Leung, et al.
Journal of Viral Hepatitis|March 15, 2020
The efficacy of hepatitis B treatments in achieving HBsAg seroclearance: A systematic review and meta-analysisMariana Alves Fonseca, Joanna Zhi Jie Ling, Omar Al-Siyabi, et al.
Antisense & Nucleic Acid Drug Development|September 20, 2002
Intracellular inhibition of hepatitis B virus S gene expression by chimeric DNA-RNA phosphorothioate minimized ribozymeTheresa May Chin Tan, Lei Zhou, Sandrine Houssais, et al.
World Journal of Gastroenterology|July 23, 2005
Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhoticsYock-Young Dan, Chun-Tao Wai, Yin-Mei Lee, et al.
Molecular Cancer|March 24, 2012
Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinomaWeijie Poh, Winnie Wong, Huimin Ong, et al.
Gut|November 17, 2016
Ethics and hepatitis B cure researchJeremy Sugarman, Peter Revill, Fabien Zoulim, et al.
Transplantation|November 15, 2006
Impact of new legislation on presumed consent on organ donation on liver transplant in Singapore: a preliminary analysisHow-Cheng Low, Maureen Da Costa, Krishnan Prabhakaran, et al.
Virology|April 23, 2003
CD81 engineered with endocytotic signals mediates HCV cell entry: implications for receptor usage by HCV in vivoYee-Joo Tan, Siew-Pheng Lim, Patrick Ng, et al.
Proteomics|November 13, 2008
2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesisRamdzan M Zubaidah, Gek San Tan, Sandra B E Tan, et al.
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseasesYonghai Lu, Jinling Fang, Li Zou, et al.
Pageof 25

Showing results (71-80 of 241) with videos related to

Sort By:
Pageof 25
Journal of Gastroenterology and Hepatology|June 15, 2007
How should we manage patients with non-alcoholic fatty liver disease in 2007?Henry L-Y Chan, H Janaka de Silva, Nancy W-Y Leung, et al.
Journal of Viral Hepatitis|March 15, 2020
The efficacy of hepatitis B treatments in achieving HBsAg seroclearance: A systematic review and meta-analysisMariana Alves Fonseca, Joanna Zhi Jie Ling, Omar Al-Siyabi, et al.
Antisense & Nucleic Acid Drug Development|September 20, 2002
Intracellular inhibition of hepatitis B virus S gene expression by chimeric DNA-RNA phosphorothioate minimized ribozymeTheresa May Chin Tan, Lei Zhou, Sandrine Houssais, et al.
World Journal of Gastroenterology|July 23, 2005
Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhoticsYock-Young Dan, Chun-Tao Wai, Yin-Mei Lee, et al.
Molecular Cancer|March 24, 2012
Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinomaWeijie Poh, Winnie Wong, Huimin Ong, et al.
Gut|November 17, 2016
Ethics and hepatitis B cure researchJeremy Sugarman, Peter Revill, Fabien Zoulim, et al.
Transplantation|November 15, 2006
Impact of new legislation on presumed consent on organ donation on liver transplant in Singapore: a preliminary analysisHow-Cheng Low, Maureen Da Costa, Krishnan Prabhakaran, et al.
Virology|April 23, 2003
CD81 engineered with endocytotic signals mediates HCV cell entry: implications for receptor usage by HCV in vivoYee-Joo Tan, Siew-Pheng Lim, Patrick Ng, et al.
Proteomics|November 13, 2008
2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesisRamdzan M Zubaidah, Gek San Tan, Sandra B E Tan, et al.
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseasesYonghai Lu, Jinling Fang, Li Zou, et al.
Pageof 25